TE_54
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2a_3end |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | RPL22 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 1.17 |
| Counts of samples | TCGA_tumor:340; TCGA_normal:22; GTEx:305 |
| TSS | chr1(-):6203318 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_54.1 | RPL22 | Chimeric | Non-coding | Non-coding | chr1(-):6193034,6193054,6197652,6197756,6200489,6200750,6203267,6203319 |
| teRNA_54.2 | RPL22 | Chimeric | Non-coding | Non-coding | chr1(-):6193034,6193054,6197652,6197756,6200489,6200727,6203267,6203319 |
| teRNA_54.3 | RPL22 | Chimeric | Non-coding | Non-coding | chr1(-):6186796,6186816,6192930,6193054,6197652,6197756,6200489,6200832,6203267,6203319 |
| teRNA_54.4 | RPL22 | Chimeric | Non-coding | Non-coding | chr1(-):6193034,6193054,6197652,6197756,6200489,6200832,6203267,6203319 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
